Ad blocker detected: Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.
PREVENTION AND CONTROL OF LASSA FEVER.
Forum rules
The information contained on this web site is for information purposes and is not intended to treat, diagnose, cure or prevent any disease.
The information contained on this web site is for information purposes and is not intended to treat, diagnose, cure or prevent any disease.
- Kunle Emmanuel
- Webmaster
- Reactions:
- Posts: 3339
- Joined: Mon Jan 09, 2012 5:02 pm
- Years of practice: 20
- Location: Lagos
- Contact:
PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by Kunle Emmanuel »
Prevention of Lassa fever relies on promoting good “community hygiene” to discourage rodents from entering homes. Effective measures include storing grain and other foodstuffs in rodent-proof containers, disposing of garbage far from the home, maintaining clean households and keeping cats. Because Mastomys are so abundant in endemic areas, it is not possible to completely eliminate them from the environment. Family members should always be careful to avoid contact with blood and body fluids while caring for sick persons.
In health-care settings, staff should always apply standard infection prevention and control precautions when caring for patients, regardless of their presumed diagnosis. These include basic hand hygiene, respiratory hygiene, use of personal protective equipment (to block splashes or other contact with infected materials), safe injection practices and safe burial practices.
Health-care workers caring for patients with suspected or confirmed Lassa fever should apply extra infection control measures to prevent contact with the patient’s blood and body fluids and contaminated surfaces or materials such as clothing and bedding. When in close contact (within 1 metre) of patients with Lassa fever, health-care workers should wear face protection (a face shield or a medical mask and goggles), a clean, non-sterile long-sleeved gown, and gloves (sterile gloves for some procedures).
Laboratory workers are also at risk. Samples taken from humans and animals for investigation of Lassa virus infection should be handled by trained staff and processed in suitably equipped laboratories under maximum biological containment conditions.
On rare occasions, travellers from areas where Lassa fever is endemic export the disease to other countries. Although malaria, typhoid fever, and many other tropical infections are much more common, the diagnosis of Lassa fever should be considered in febrile patients returning from West Africa, especially if they have had exposures in rural areas or hospitals in countries where Lassa fever is known to be endemic. Health-care workers seeing a patient suspected to have Lassa fever should immediately contact local and national experts for advice and to arrange for laboratory testing.
In health-care settings, staff should always apply standard infection prevention and control precautions when caring for patients, regardless of their presumed diagnosis. These include basic hand hygiene, respiratory hygiene, use of personal protective equipment (to block splashes or other contact with infected materials), safe injection practices and safe burial practices.
Health-care workers caring for patients with suspected or confirmed Lassa fever should apply extra infection control measures to prevent contact with the patient’s blood and body fluids and contaminated surfaces or materials such as clothing and bedding. When in close contact (within 1 metre) of patients with Lassa fever, health-care workers should wear face protection (a face shield or a medical mask and goggles), a clean, non-sterile long-sleeved gown, and gloves (sterile gloves for some procedures).
Laboratory workers are also at risk. Samples taken from humans and animals for investigation of Lassa virus infection should be handled by trained staff and processed in suitably equipped laboratories under maximum biological containment conditions.
On rare occasions, travellers from areas where Lassa fever is endemic export the disease to other countries. Although malaria, typhoid fever, and many other tropical infections are much more common, the diagnosis of Lassa fever should be considered in febrile patients returning from West Africa, especially if they have had exposures in rural areas or hospitals in countries where Lassa fever is known to be endemic. Health-care workers seeing a patient suspected to have Lassa fever should immediately contact local and national experts for advice and to arrange for laboratory testing.
Together We Light Up The Profession one candle at a time.
- Kunle Emmanuel
- Webmaster
- Reactions:
- Posts: 3339
- Joined: Mon Jan 09, 2012 5:02 pm
- Years of practice: 20
- Location: Lagos
- Contact:
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by Kunle Emmanuel »
Humans usually become infected with Lassa virus from exposure to urine or faeces of infected Mastomys rats. Lassa virus may also be spread between humans through direct contact with the blood, urine, faeces, or other bodily secretions of a person infected with Lassa fever. There is no epidemiological evidence supporting airborne spread between humans. Person-to-person transmission occurs in both community and health-care settings, where the virus may be spread by contaminated medical equipment, such as re-used needles. Sexual transmission of Lassa virus has been reported.
Lassa fever occurs in all age groups and both sexes. Persons at greatest risk are those living in rural areas where Mastomys are usually found, especially in communities with poor sanitation or crowded living conditions. Health workers are at risk if caring for Lassa fever patients in the absence of proper barrier nursing and infection prevention and control practices.
Lassa fever occurs in all age groups and both sexes. Persons at greatest risk are those living in rural areas where Mastomys are usually found, especially in communities with poor sanitation or crowded living conditions. Health workers are at risk if caring for Lassa fever patients in the absence of proper barrier nursing and infection prevention and control practices.
Together We Light Up The Profession one candle at a time.
- Kunle Emmanuel
- Webmaster
- Reactions:
- Posts: 3339
- Joined: Mon Jan 09, 2012 5:02 pm
- Years of practice: 20
- Location: Lagos
- Contact:
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by Kunle Emmanuel »
The incubation period of Lassa fever ranges from 2–21 days. The onset of the disease, when it is symptomatic, is usually gradual, starting with fever, general weakness, and malaise. After a few days, headache, sore throat, muscle pain, chest pain, nausea, vomiting, diarrhoea, cough, and abdominal pain may follow. In severe cases facial swelling, fluid in the lung cavity, bleeding from the mouth, nose, vagina or gastrointestinal tract and low blood pressure may develop.
Protein may be noted in the urine. Shock, seizures, tremor, disorientation, and coma may be seen in the later stages. Deafness occurs in 25% of patients who survive the disease. In half of these cases, hearing returns partially after 1–3 months. Transient hair loss and gait disturbance may occur during recovery.
Death usually occurs within 14 days of onset in fatal cases. The disease is especially severe late in pregnancy, with maternal death and/or fetal loss occurring in more than 80% of cases during the third trimester.
Diagnosis
Because the symptoms of Lassa fever are so varied and non-specific, clinical diagnosis is often difficult, especially early in the course of the disease. Lassa fever is difficult to distinguish from other viral haemorrhagic fevers such as Ebola virus disease as well as other diseases that cause fever, including malaria, shigellosis, typhoid fever and yellow fever.
Definitive diagnosis requires testing that is available only in reference laboratories. Laboratory specimens may be hazardous and must be handled with extreme care. Lassa virus infections can only be diagnosed definitively in the laboratory using the following tests:
1. reverse transcriptase polymerase chain reaction (RT-PCR) assay
2. antibody enzyme-linked immunosorbent assay (ELISA)
3. antigen detection tests
4. virus isolation by cell culture.
Treatment.
The antiviral drug ribavirin seems to be an effective treatment for Lassa fever if given early on in the course of clinical illness. There is no evidence to support the role of ribavirin as post-exposure prophylactic treatment for Lassa fever.
There is currently no vaccine that protects against Lassa fever.
Protein may be noted in the urine. Shock, seizures, tremor, disorientation, and coma may be seen in the later stages. Deafness occurs in 25% of patients who survive the disease. In half of these cases, hearing returns partially after 1–3 months. Transient hair loss and gait disturbance may occur during recovery.
Death usually occurs within 14 days of onset in fatal cases. The disease is especially severe late in pregnancy, with maternal death and/or fetal loss occurring in more than 80% of cases during the third trimester.
Diagnosis
Because the symptoms of Lassa fever are so varied and non-specific, clinical diagnosis is often difficult, especially early in the course of the disease. Lassa fever is difficult to distinguish from other viral haemorrhagic fevers such as Ebola virus disease as well as other diseases that cause fever, including malaria, shigellosis, typhoid fever and yellow fever.
Definitive diagnosis requires testing that is available only in reference laboratories. Laboratory specimens may be hazardous and must be handled with extreme care. Lassa virus infections can only be diagnosed definitively in the laboratory using the following tests:
1. reverse transcriptase polymerase chain reaction (RT-PCR) assay
2. antibody enzyme-linked immunosorbent assay (ELISA)
3. antigen detection tests
4. virus isolation by cell culture.
Treatment.
The antiviral drug ribavirin seems to be an effective treatment for Lassa fever if given early on in the course of clinical illness. There is no evidence to support the role of ribavirin as post-exposure prophylactic treatment for Lassa fever.
There is currently no vaccine that protects against Lassa fever.
Together We Light Up The Profession one candle at a time.
-
- Reactions:
- Posts: 3
- Joined: Fri Jun 28, 2019 9:38 am
- Years of practice: 5
- Contact:
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by keithevans »
- Regular hand-washing
storing foods in rodent-proof containers
keeping garbage away from the home
keeping pet cats
avoiding blood and other bodily fluids when caring for sick relatives
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by pugnip »
Your blog is too much amazing. I have found with ease what I was looking. Moreover, the content quality is awesome. Thanks for the nudge!
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by ASDF123 »
I am continually amazed by the amount of information available on this subject. What you presented was well researched and well worded in order to get your stand on this across to all your readers.
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by ASDF123 »
Thanks for sharing this quality information with us. I really enjoyed reading. Will surely going to share this URL with my friends. Cugir
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by ASDF123 »
Nice to be visiting your blog again, it has been months for me. Well this article that i’ve been waited for so long. I need this article to complete my assignment in the college, and it has same topic with your article. Thanks, great share. best delta 8 gummies
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by Jaan »
http://doramasflix.mxKunle Emmanuel wrote: ↑Tue Dec 20, 2016 1:32 pm Prevention of Lassa fever relies on promoting good “community hygiene” to discourage rodents from entering homes. Effective measures include storing grain and other foodstuffs in rodent-proof containers, disposing of garbage far from the home, maintaining clean households and keeping cats. Because Mastomys are so abundant in endemic areas, it is not possible to completely eliminate them from the environment. Family members should always be careful to avoid contact with blood and body fluids while caring for sick persons.
In health-care settings, staff should always apply standard infection prevention and control precautions when caring for patients, regardless of their presumed diagnosis. These include basic hand hygiene, respiratory hygiene, use of personal protective equipment (to block splashes or other contact with infected materials), safe injection practices and safe burial practices.
Health-care workers caring for patients with suspected or confirmed Lassa fever should apply extra infection control measures to prevent contact with the patient’s blood and body fluids and contaminated surfaces or materials such as clothing and bedding. When in close contact (within 1 metre) of patients with Lassa fever, health-care workers should wear face protection (a face shield or a medical mask and goggles), a clean, non-sterile long-sleeved gown, and gloves (sterile gloves for some procedures).
Laboratory workers are also at risk. Samples taken from humans and animals for investigation of Lassa virus infection should be handled by trained staff and processed in suitably equipped laboratories under maximum biological containment conditions.
On rare occasions, travellers from areas where Lassa fever is endemic export the disease to other countries. Although malaria, typhoid fever, and many other tropical infections are much more common, the diagnosis of Lassa fever should be considered in febrile patients returning from West Africa, especially if they have had exposures in rural areas or hospitals in countries where Lassa fever is known to be endemic. Health-care workers seeing a patient suspected to have Lassa fever should immediately contact local and national experts for advice and to arrange for laboratory testing.
Re: PREVENTION AND CONTROL OF LASSA FEVER.
Unread post by ASDF123 »
Awesome article! I want people to know just how good this information is in your article. It’s interesting, compelling content. Your views are much like my own concerning this subject. joyas de plata por mayor
-
- Similar Topics
- Replies
- Views
- Last post
-
-
COVID-19: infection prevention and control advice for all Nurses after end shift
Replies: 2by Kunle Emmanuel » Thu Apr 23, 2020 4:16 pm » in Nursing Related News & Articles - 2 Replies
- 5480 Views
-
Last post by Kunle Emmanuel
Sat Apr 25, 2020 2:43 pm
-
-
-
RECURRENT MISCARRIAGES CAUSES TREATMENT AND PREVENTION
Replies: 5by Queenet » Fri Sep 04, 2020 4:17 pm » in Maternal & Child Health Education - 5 Replies
- 5350 Views
-
Last post by Akpan
Thu May 12, 2022 9:38 am
-
Return to “Public Health Education”
Jump to
- Announcements, Feedback & Support
- ↳ Welcome Message To All Visitors
- ↳ Announcement & Tutorial
- ↳ Forum Rules - Read Before Posting
- Nursing News
- ↳ Nursing Related News & Articles
- ↳ Nurse to Nurse Discussion
- ↳ General Health News
- ↳ Male Nurses
- ↳ Retired Nurses
- Jobs in Nursing and Healthcare
- ↳ Nursing Job & Recruitment
- MCPDP for Nurses & Midwives
- ↳ MCPDP for Nurses & Midwives
- ↳ Continuous Education
- Nursing Education
- ↳ Student Nurses Discussion and News
- ↳ Nursing Inspirations, Jokes, and Quotes
- Public Health Adviser
- ↳ Public Health Education
- ↳ Maternal & Child Health Education
- ↳ Sexual Health Education
- ↳ Public Discussion Forum
- Clinical Nursing Discussion
- ↳ Clinical Nursing Blog
- ↳ Specialty Nursing Discussion Forum
- ↳ Free Nursing e-Book
- ↳ MEDICAL EDUCATIONAL VIDEOS HD
- Nursing Digital Skill Empowerment Program
- ↳ Nursing Digital Skill Program
- Workplace Safety Forum
- ↳ Safety Health Enviroment SHE Topics
- Marketing Online
- ↳ Marketing Medical Products
Who is online
Users browsing this forum: No registered users and 33 guests